Automating Medication Reconciliation Prior Auth for Specialty Medications
Klivira streamlines the complex process of medication reconciliation prior auth, ensuring timely approvals for critical specialty medications post-discharge. Our platform automates the submission and tracking of authorizations, reducing administrative burden and improving patient access.
The transition of care, particularly post-discharge, presents significant challenges for medication management, especially when non-formulary specialty medications require prior authorization. Revenue cycle directors and prior authorization coordinators face increased denial risks and delayed patient care if these critical steps are not managed efficiently. Klivira offers a robust solution to integrate and automate the medication reconciliation prior auth workflow.
The Challenge of Post-Discharge Specialty Medication PAs
Post-discharge medication reconciliation often uncovers new or changed specialty medication regimens that require immediate prior authorization. Manual processes for these non-formulary drugs are prone to errors, lead to significant delays, and contribute to higher denial rates, directly impacting patient continuity of care and institutional revenue.
Common Pain Points in Med Rec Prior Authorization
- Identifying non-formulary specialty medications requiring new PAs during med rec.
- Manual submission of X12 278 requests for complex specialty drugs.
- Tracking multi-step authorization processes across different payer portals.
- High denial rates due to incomplete documentation or delayed submissions.
- Lack of real-time visibility into PA status for discharge planners.
Klivira's Automated Solution for Medication Reconciliation Prior Auth
Klivira integrates directly with your EMR to flag specialty medications identified during medication reconciliation that require prior authorization. Our platform then automates the initiation, submission, and tracking of these PAs, leveraging intelligent rules engines to ensure all necessary clinical documentation is attached and submitted.
Leveraging Industry Standards for Seamless Integration
Klivira supports key industry standards such as X12 278 for electronic prior authorization and integrates via SMART on FHIR for seamless data exchange with EMR systems. This ensures accurate and efficient transfer of patient demographics, clinical notes, and medication lists, critical for comprehensive medication reconciliation prior auth workflows. We also support Da Vinci PAS and NCPDP SCRIPT where applicable for specific medication types.
Tangible Benefits for Revenue Cycle and Patient Care
By automating medication reconciliation prior auth, Klivira significantly reduces the administrative burden on PA teams, minimizes manual errors, and accelerates approval times. This leads to fewer claim denials, improved revenue capture for specialty medications, and ensures patients receive their critical therapies without unnecessary delays post-discharge.
Frequently asked questions
How does Klivira identify medications requiring prior auth during medication reconciliation?
Klivira integrates with your EMR to access medication lists and patient data. Our rules engine cross-references prescribed specialty medications with payer formularies and authorization requirements, automatically flagging those needing a new or updated prior authorization during the medication reconciliation process.
What EMR integration capabilities does Klivira offer for this workflow?
Klivira offers robust EMR integration capabilities, including SMART on FHIR, to facilitate seamless data exchange for medication reconciliation prior auth. This allows for direct access to patient demographics, medication history, and clinical documentation, minimizing manual data entry and ensuring data accuracy.
How does Klivira help reduce denials specifically for specialty medications post-discharge?
Klivira reduces denials by ensuring complete and accurate submission of prior authorization requests for specialty medications. Our platform automates the gathering of required clinical documentation, enforces payer-specific rules, and facilitates timely submission, addressing common causes of denials in the post-discharge phase.
Does Klivira support electronic prior authorization (ePA) for specialty medications identified during med rec?
Yes, Klivira fully supports electronic prior authorization (ePA) for specialty medications. We leverage standards like X12 278 and NCPDP SCRIPT to submit requests directly to payers, streamlining the process and improving turnaround times for critical therapies identified during medication reconciliation.
What considerations should our compliance team be aware of regarding Klivira's handling of PHI for medication reconciliation prior auth?
Klivira is designed with HIPAA compliance in mind, ensuring secure handling of PHI throughout the medication reconciliation prior auth workflow. Data is encrypted in transit and at rest, and access controls are rigorously managed. We encourage discussions with your compliance team to review our security protocols and Business Associate Agreement.
Related coverage
Ready to ship this workflow?
See how Klivira automates prior authorizations for your team.
Request a demo